Gland Pharma is one of the fastest growing generic injectable-focused companies by revenue in the United States
from 2014 to 2019 as per IQVIA report. Company sells its products primarily under a B2B model which accounted for 97% of
FY2020 revenues. Company exports to over 60 countries as of June 30, 2020, including the United States, Europe,Canada,
Australia and the Rest of the world.The company has an extensive track record in complex injectable development, manufacturing
and marketing.
Date: Nov 9, 2020 - Nov 11, 2020
Price range: Rs.1,490 - 1,500
Issuer Company: Gland Pharma Limited
IPO Lot Size: 10 Equity Shares and in multiples thereof
Click here to APPLY NOW
Watch Now IPO Review & Analysis Report
Click here to know: How to Apply for IPO On Angel Broking?
You can check NPCI explanation of the UPI ASBA process here in
Sindhi,
Gujarati,
Tamil,
Hindi and
English
